February 24th, 2009

WHYY on Social Media and Health

To help me face the day, I usually wake up to the news from my local National Public Radio affiliate, WHYY out of Philadelphia. This AM, as I digested the latest on the bailout package and other news, I had a pleasant surprise.

WHYY’s health and science reporter, Kerry Grens, did a short, yet thoughtful piece on the complexities faced by companies in the highly regulated pharmaceutical industry as they try to use social media to interact with the people who use their products.

Through a series of interviews, some of which were conducted at the recent ePharma conference in Philly (that’s where she interviewd me and Steve Woodruff) Kerry explained that as people increasingly trust health information provided by other like-minded individuals online rather than more traditional advertising or marketing messages, companies are trying to get their arms around how best they too can be part of those online conversations.

It isn’t easy. As Kerry pointed out, one big hurdle is “something called adverse event reporting” that companies need to report to the Food and Drug Administration.

Now those who read this blog know that I’ve often discussed approaches taken by Johnson & Johnson, our operating companies and others to get involved online . (here, here and here, for instance) Getting involved not only requires an understanding of the risks, but also new processes to handle adverse event reports and ensuring there are people involved who can respond quickly to questions or new developments.

As I’ve said before, though, it is only by experimenting and trying out new approaches (perhaps by first taking small steps ) that you can get a true understanding of the risks and how best to mitigate them. Yet it is also important for people who are looking for information and connections online to understand the limitations that companies in highly-regulated industries are under — and that what may look like “baby steps” are really earnest efforts to get involved.

The complete podcast of the segment is available on WHYY’s site.

One Response to “WHYY on Social Media and Health”

  1. Linda Margaret says

    Having worked in Health 2.0 for over a year now, it becoming more or less my specialty at my current job, I have to agree with regard to the comment on Adverse Event reporting.

    It’s difficult to engage given some of the current FDA regulations and the more traditional reporting methods.

    A central, online, government office to which both consumers and professionals could submit concerns and events might make managing the events easier, faster, and more transparent. We could all view which drugs are getting the most AE buzz and which aren’t–this might improve “Big Pharma”‘s image as well, proving that these companies may be profit motivated, but that in the end they feel a good profit comes from a good, clean product.

Leave a Reply

All comments will be reviewed before posting. Since this blog is about Johnson & Johnson, comments that don’t directly relate to the Company or to topics covered on this blog won’t be posted. Please see our comments policy for details.